Portal de Periódicos da CAPES

Nefazodone (Serzone) withdrawn because of hepatotoxicity.

2003; National Institutes of Health; Volume: 169; Issue: 11 Linguagem: Inglês

Stephen Choi,

Treatment of Major Depression

Reason for posting: Because of concerns of hepatotoxicity, the sale of the antidepressant nefazodone hydrochloride (Serzone) will be discontinued by the manufacturer effective Nov. 27, 2003. Since the drug's introduction in 1994, there have been 51 Canadian reports of adverse hepatic events,